AVALON GLOBOCARE CORP (ALBT)
NASDAQReal EstateBiotechnologySnapshot 2026-09-04
$0.23-3.14%
Close 2026-07-27 · 1-day change
NASDAQReal EstateBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ALBT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | — | — | 1.3 | 1.3 | 1.2 | 1.4 | 1.4 | 1.5 | 1.6 | 1.1 | 0.6 | — |
| Total Revenues | — | — | 1.3 | 1.3 | 1.2 | 1.4 | 1.4 | 1.5 | 1.6 | 1.1 | 0.6 | — |
| Gross Profit | — | — | — | — | 0.3 | 0.4 | 0.4 | 0.3 | 0.4 | 0.0 | (0.5) | — |
| Operating Expenses & Income | ||||||||||||
| R&D Expenses | — | — | — | 0.1 | 0.7 | 1.0 | 0.9 | 1.8 | 0.0 | — | — | — |
| Other Operating Expenses, Total | — | — | 0.3 | 0.2 | 0.3 | (0.3) | — | — | — | — | — | — |
| Operating Income | (6.7) | (7.6) | (4.9) | (15.8) | (8.8) | (8.8) | (12.5) | (19.4) | (7.6) | (3.9) | 0.1 | (0.0) |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | 1.5 | 2.4 | — | 0.2 | — | — | 0.0 | 0.3 | 0.1 | — | — |
| Other Non-Operating Income / Expenses | (1.9) | (9.9) | (3.0) | (1.0) | (3.1) | (9.1) | — | — | — | — | — | — |
| Asset Writedown | — | — | — | 0.5 | 0.0 | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | 18.3 | 7.9 | 16.7 | (11.9) | (9.1) | (12.7) | 0.0 | (8.1) | (4.0) | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | — |
| Earnings from Continuing Operations | — | — | — | — | (11.9) | (9.1) | (12.7) | — | — | — | — | — |
| Net Income | ||||||||||||
| Minority Interest | — | — | — | — | — | (9.1) | (12.7) | (0.3) | (0.3) | (0.6) | — | — |
| Net Income | (9.0) | (18.3) | (7.9) | (16.7) | (11.9) | (9.1) | (12.7) | (18.1) | (8.1) | (4.0) | 0.1 | (0.0) |
| Per Share | ||||||||||||
| Basic EPS | (0.57) | (5.64) | (8.44) | (23.80) | (1.28) | (1.07) | — | — | — | — | — | — |
| Diluted EPS | (0.57) | (5.64) | (8.44) | (23.80) | (1.28) | (1.07) | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 15.8 | 3.2 | 0.9 | 0.7 | 9.3 | 8.5 | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 15.8 | 3.2 | 0.9 | 0.7 | 9.3 | 8.5 | — | — | — | — | — | — |
| Supplemental | ||||||||||||
| EBITDA | — | — | — | — | — | — | (12.1) | (18.9) | (7.1) | (3.7) | — | — |
| EBIT | (6.7) | (7.6) | (4.9) | (15.8) | (8.8) | (8.8) | (12.5) | (19.4) | (7.6) | (3.9) | 0.1 | (0.0) |
| Effective Tax Rate | — | — | — | — | — | — | — | — | — | -0.5% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.